SCID mice (EBV+ lymphoma xenograft, literature/PD); no tox species
“Safety pharmacology studies were not conducted due to the species-specific nature of tabelecleucel and the limited applicability of non-human toxicology models.”
No surrogate; human tabelecleucel CTLs in immunodeficient SCID mice
“Inoculation of SCID mice with EBV+ BLCL results in development of EBV-induced immunoblastic B cell lymphomas with characteristics similar to EBV-PTLD arising in immunocompromised hosts”
“Single and repeat dose toxicity studies were not conducted as due to the species-specific nature of tabelecleucel these studies would yield no additional information to aid in the understanding of its potential toxicity in humans.”
Not conducted (highly species-specific pharmacology)
“Due to the highly species-specific nature of the pharmacology associated with tabelecleucel, nonclinical reproductive/developmental toxicity studies were not submitted with this application.”